Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
Clinical trial NCT00161707 · COMPLETED
Trial details
- NCT number
- NCT00161707
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-07
- Primary completion
- 2003-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.